Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/9dd25498-e4e0-4b8f-8cbd-a6237f8996be/

PRAX

Praxis Precision Medicines Inc
Chart
325.30 USD
Latest Week 2026-07-24
Snapshot 2026-07-26 · 0.9w · Fresh
0.42
OS Score
45.0%
Value
44.0%
Quality
46.0%
Momentum
3/9
F-Score
0.445
QV
Strategy Eligibility
2 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
Yes
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
RAM 1.70
V
Value Analysis
Cheapness relative to fundamentals
45.0%ile
P/B
6.4×
FCF Yield
-0.033
SH Yield
-0.139
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
55.00000000
/100 — 1=cheapest
VC2 (Trending Value)
55.00000000
/100
VC3 (Buyback)
55.00000000
/100
Negative FCF yield (-3.3%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
44.0%ile
ROE
-0.232
ROA
-0.224
GPA
-0.141
D/E
0.04
Current
15.88
F-Score
3/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Stability
0.290
lower=better
Accruals
-0.030
lower=better
5yr Consist
Yes
Conservative balance sheet with D/E of 0.04.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
46.0%ile
6M Return
4.4%
12M Return
449.3%
12-1 Mom
453.5%
Risk-Adj
1.70
Vol 252d
266.8%
Vol 60d
140.5%
↓ Contracting
Max DD 12M
-30.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 454% is very strong — a clear uptrend. Risk-adjusted momentum of 1.70 is excellent — strong returns relative to volatility. Volatility is compressing — 60d (140%) well below 252d (267%).
OS
Composite & Factor Heatmap
All factors at a glance
0.42
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
10.0%
Sector Quality %ile
9.0%
P/B z-score
0.00
Sector Avg OS
64.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
FBIO Fortress Biotech Inc 99.0% 98.0% 84.0% 87.0%
NUTX Nutex Health Inc 99.0% 93.0% 98.0% 87.0%
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 97.0%
IRWD Ironwood Pharmaceuticals Inc 99.0% 92.0% 90.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 99.0% 92.0% 93.0% 92.0%
TBPH Theravance Biopharma Inc 98.0% 90.0% 99.0% 86.0%
CGEN Compugen 98.0% 90.0% 96.0% 83.0%
MD Mednax Inc 97.0% 86.0% 84.0% 94.0%
Factor Interactions
Volatility Compressing
60-day vol (140%) well below 252-day (267%). Price action is stabilising.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
7.0% avg (3 factors)
Quality
C
45.2% avg (6 factors)
Momentum
A
77.6% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.420—0
Value %ile0.450—0
Quality %ile0.440—0
Momentum %ile0.460—0
F-Score3.000—8
Confidence0.639—0
Volatility2.668—8
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Book
6.43
FCF Yield
-3.3%
Shareholder Yield
Div + net buyback / mktcap
-13.9%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-23.2%
Return on Assets
-22.4%
Gross Profit / Assets
Novy-Marx GPA
-14.1%
Debt / Equity
0.04
Current Ratio
15.88
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.030
MomentumPrice trend strength over different horizons
6M Return
4.4%
12M Return
449.3%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
453.5%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.70
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Earnings Stability (CV)
Lower = more stable
0.290
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
3
Buyback Yield
-13.9%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
55
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
55
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
55
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity